Atlas Trials

NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy

Clinical trial NCT02319824 · COMPLETED

Trial details

NCT number
NCT02319824
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sarcoma
Start date
2015-01-01
Primary completion
2015-06-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.